The Impact of Renal Dysfunction on Aprotinin Pharmacokinetics During Cardiopulmonary Bypass
- 1 November 1999
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 89 (5) , 1101-1107
- https://doi.org/10.1097/00000539-199911000-00006
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Inhaled Nitric Oxide Primes Lung Macrophages to Produce Reactive Oxygen and Nitrogen IntermediatesAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Variable response to inhaled nitric oxide after cardiac surgeryThe Annals of Thoracic Surgery, 1997
- Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: A pharmacodynamic studyJournal of Cardiothoracic and Vascular Anesthesia, 1996
- Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.American Journal of Respiratory and Critical Care Medicine, 1995
- Free Radical Chemistry of Nitric OxideChest, 1994
- Inhaled Nitric Oxide after Mitral Valve Replacement in Patients with Chronic Pulmonary Artery HypertensionAnesthesiology, 1992
- Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.Circulation, 1991
- Vasodilator Therapy in Microembolic Porcine Pulmonary HypertensionAnesthesia & Analgesia, 1990
- Vasodilator Therapy in Vasoconstrictor-induced Pulmonary Hypertension in SheepAnesthesiology, 1988
- Intravenous Glyceryl Trinitrate (Nitroglycerin) A Review of its Pharmacological Properties and Therapeutic EfficacyDrugs, 1984